Phorbol 12-myristate 13-acetate, a PKC activator, was shown to increase lactic acid uptake in rhabdomyosarcoma cells as well as to increase MCT1 protein and mRNA levels (Narumi et al. 2010). Here, PRRT2 is linked to rhabdomyosarcoma.